Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
- A Real-World Study of Second-line Therapies Among Radioiodine-refractory Differentiated Thyroid Cancer (RAI-R DTC) PatientsNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Radioiodine-refractory Differentiated Thyroid Cancer
- A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Prostate Cancer Metastatic
United States
Sponsor: Novartis Pharmaceuticals
Ankylosing Spondylitis
South Korea
Sponsor: Novartis Pharmaceuticals
Advanced Malignancies and Hepatic Impairment
France, Italy, Spain, United Kingdom
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +29 more
Sponsor: Novartis Pharmaceuticals
Kidney Diseases · Kidney Diseases, Chronic · Urological Diseases · Glomerulonephritis
United States, Argentina, Australia, Canada, Malaysia +4 more
- A Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy PatientsNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Spinal Muscular Atrophy
Sponsor: Cancer Research UK
Haematological Malignancy · Malignant Neoplasm · Lymphoproliferative Disorders · Neoplasms by Histologic Type
United Kingdom
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria
Russia
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Non-small Cell Lung Cancer · Locally Advanced Disease
France
Sponsor: Olema Pharmaceuticals, Inc.
Breast Cancer · Locally Advanced Breast Cancer · Metastatic Breast Cancer · ER Positive Breast Cancer
United States, Australia, Austria, Belgium, Canada +18 more
Sponsor: Novartis Pharmaceuticals
Plaque Psoriasis · Metabolic Dysfunction-Associated Steatotic Liver Disease
Spain
Sponsor: M.D. Anderson Cancer Center
Chronic Myeloid Leukemia
United States
Sponsor: Novartis Pharmaceuticals
Essential Hypertension
United States
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States
- The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential ThrombocythemiaActive Not Recruiting
Sponsor: RWTH Aachen University
Polycythemia Vera (PV) · Essential Thrombocythemia (ET)
Germany
- A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in KoreaCompleted
Sponsor: Novartis Pharmaceuticals
Graft-versus-Host Disease
South Korea
- Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease PatientsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Sickle Cell Disease (SCD)
United States, Belgium, Brazil, Canada, Colombia +16 more
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
United States, Argentina, Austria, Belgium, Bulgaria +14 more
- Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive SurgeryActive Not Recruiting
Sponsor: Stanford University
Gastroenteropancreatic Neuroendocrine Tumor
United States
- A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Generalized Myasthenia Gravis
United States, Argentina, Australia, Brazil, China +13 more
- Overcoming Racial Disparities in Screening MammographyNot Yet Recruiting
Sponsor: Washington University School of Medicine
Breast Cancer · Cancer of the Breast
United States
Sponsor: Novartis Pharmaceuticals
Papulopustular Rosacea
United States, Canada, South Korea
- Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States, Germany, Italy, Poland, United Kingdom
Sponsor: Novartis Pharmaceuticals
Chronic Myeloid Leukemia
United States, Argentina, Australia, Belgium, Brazil +13 more